AirSculpt revenue stagnates at $39M as company pivots to debt reduction

AirSculpt Technologies (NASDAQ:AIRS) reported flat revenue for the first quarter of 2026 as the body contouring specialist prioritized balance sheet fortification over aggressive top-line expansion.

AirSculpt Technologies announced first-quarter revenue of $39.4 million, remaining unchanged compared to the same period in the prior year.

The company recorded a net loss of $2.4 million for the quarter ended March 31, 2026, while generating adjusted EBITDA of $3.3 million.

Operational metrics showed marginal improvement, with case volumes rising 0.2% to 3,082 procedures and same-center sales increasing by 1%.

The quarterly report highlighted a concerted effort to manage the company's capital structure through the use of an at-the-market (ATM) equity offering.

AirSculpt raised $14.6 million through the facility during the quarter, deploying $11.4 million of those proceeds toward debt repayment.

The company ended the period with a liquidity profile consisting of $16.7 million in cash, approximately $45.6 million in gross debt, and $5 million of remaining capacity on its revolving credit line.

Management reaffirmed its financial outlook for the full fiscal year 2026, signaling stability in the demand for its proprietary fat-removal procedures.

The company continues to expect total revenue in the range of $151 million to $157 million and adjusted EBITDA between $15 million and $17 million.